Related Experiment Video
Updated: Aug 15, 2025
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Is There a Role for Coronary Calcium in Patients With Diabetes?
Scott M Grundy1, Gloria L Vega2, Nathan D Wong3
1Center for Human Nutrition, Departments of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Veterans Affairs North Texas Health Care System Dallas, Texas.
Insights
Routine statin therapy for diabetes patients in primary prevention of atherosclerotic cardiovascular disease (ASCVD) may need re-evaluation. Coronary artery calcium scoring can help personalize statin initiation decisions for these high-risk individuals.
Area of Science:
- Cardiology
- Endocrinology
- Preventive Medicine
Background:
- Diabetes significantly increases atherosclerotic cardiovascular disease (ASCVD) risk.
- Historically, patients with diabetes were considered coronary heart disease (CHD) risk equivalents, prompting routine statin use.
- Recent improvements in diabetes management have reduced ASCVD risk in this population.
Purpose of the Study:
- To re-evaluate the recommendations for routine statin therapy in patients with diabetes for primary ASCVD prevention.
- To examine the role of coronary artery calcium (CAC) scanning in guiding statin initiation decisions.
Main Methods:
- Review of current guidelines and evidence regarding statin therapy in diabetic patients.
- Analysis of the utility of coronary artery calcium scoring in ASCVD risk stratification.
- Assessment of the impact of improved diabetes treatment on cardiovascular risk.
Main Results:
- Evidence suggests a potential need to reconsider universal statin recommendations for all diabetic patients.
- Coronary artery calcium scoring offers a more personalized approach to ASCVD risk assessment.
- CAC scores can help identify individuals who would benefit most from statin therapy.
Conclusions:
- Routine statin therapy may not be necessary for all patients with diabetes undergoing primary prevention.
- Coronary artery calcium scanning is a valuable tool for refining statin initiation decisions in diabetic individuals.
- Personalized risk assessment using CAC scoring can optimize primary prevention strategies for ASCVD in diabetes.
Abstract:
In the primary prevention of atherosclerotic cardiovascular disease (ASCVD), a significant portion of high-risk patients have diabetes. Two decades ago, patients with or without cardiovascular disease were identified as having coronary heart disease (CHD) risk equivalents because prospective studies showed that they were at risk for future CHD events equivalent to that of patients with established CHD. Thus, for patients with CHD, cholesterol guidelines recommended that patients with diabetes should be treated routinely with statins. However, recently, the treatment of diabetes has been greatly improved, and the risk for ASCVD has decreased. For this reason, it may be appropriate to re-evaluate the recommendations for routine use of statins in patients with diabetes. One of the major advances in the risk assessment for ASCVD is the introduction of coronary artery calcium measurement. This report will examine the role of coronary artery calcium scanning for the decision to initiate statin therapy in the primary prevention for patients with diabetes.
More Related Videos
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:26Coronary Artery Disease IV: Preventive Measures
01:30Coronary Artery Disease I: Introduction
01:27Coronary Artery Disease V: Interprofessional Care
01:26Coronary Artery Disease II: Pathophysiology
01:28Imaging Studies for Cardiovascular System V: CT